Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia - Vogiatzi, Fotini; Winterberg, Dorothee; Lenk, Lennart; Buchmann, Swantje; Cario, Gunnar; Schrappe, Martin; Peipp, Matthias; Richter-Pechańska, Paulina; Kulozik, Andreas; Lentes, Jana; Bergmann, Anke K.; Valerius, Thomas; et al. (Blood, 2019)
Gesehen am 08.12.2020